FARMINGTON, Conn., April 16, 2012 /PRNewswire-iReach/ -- Global Information Inc. is pleased to announce two significant new developments in biotechnology and biomarker market research with the release of the Venture Planning Group's annual survey of the US molecular diagnostics market, available immediately, and remaining limited registration for the Biomarker World Congress in Philadelphia in May.
The 2012 US Molecular Diagnostics Market
The Venture Planning Group has released the 2012 edition of their annual report on the state of the US molecular diagnostics market. Spanning 880 pages and including 37 tables of data, this market research report presents a comprehensive analysis of the US molecular diagnostics market, including major issues pertaining to the US molecular diagnostics laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years.
Buyers will also gain access to an extensive review of DNA probe and biochip technologies, test formats, detection methodologies, and trends in testing automation and amplification methods. The report highlights ten-year test volume and reagent sales forecasts in the categories of infectious diseases, genetic diseases, cancer, paternity testing, HLA typing, and forensic testing. Also, the topics of testing methodologies and instrumentation technologies, as well as a feature comparison of automated and semiautomated analyzers and sales and market shares of leading suppliers are all compiled. In sum, over 60 specific opportunities for molecular diagnostic instruments, test systems, IT and auxiliary products are discussed.
|SOURCE Global Information Inc.|
Copyright©2010 PR Newswire.
All rights reserved